CD33 and acute myeloid leukemia: AML blasts from the majority of cases with NPMc+ mutation show morphological signs of differentiation and the CD34-CD33+ phenotype associated with common myeloid progenitors rather than with stem cells supporting the notion of dichotomous Wnt activation in this AML subtype [28,29].